Meag Munich Ergo’s Taubman Centers Inc. TCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-54,450
Closed -$1.81M 215
2020
Q3
$1.81M Hold
54,450
0.34% 76
2020
Q2
$2.06M Hold
54,450
0.39% 73
2020
Q1
$2.28M Sell
54,450
-253,400
-82% -$10.6M 0.54% 58
2019
Q4
$9.46M Hold
307,850
1.01% 21
2019
Q3
$12.8M Buy
307,850
+29,400
+11% +$1.2M 0.66% 37
2019
Q2
$11.4M Buy
278,450
+13,700
+5% +$659K 0.89% 23
2019
Q1
$14.1M Buy
264,750
+11,700
+5% +$593K 1.16% 14
2018
Q4
$11.6M Buy
253,050
+20,700
+9% +$1.09M 1.43% 13
2018
Q3
$13.5M Hold
232,350
0.8% 25
2018
Q2
$13.9M Buy
232,350
+9,350
+4% +$525K 0.86% 25
2018
Q1
$12.8M Hold
223,000
0.52% 47
2017
Q4
$14.7M Buy
223,000
+40,587
+22% +$2.23M 0.57% 42
2017
Q3
$9.21M Buy
182,413
+53,713
+42% +$2.95M 0.38% 94
2017
Q2
$7.73M Buy
128,700
+16,500
+15% +$1.02M 0.34% 98
2017
Q1
$7.29M Hold
112,200
0.29% 126
2016
Q4
$8.2M Hold
112,200
0.38% 92
2016
Q3
$8.4M Hold
112,200
0.41% 83
2016
Q2
$8.3M Buy
112,200
+27,800
+33% +$1.96M 0.75% 47
2016
Q1
$6M Buy
84,400
+14,000
+20% +$992K 0.31% 107
2015
Q4
$5.43M Hold
70,400
0.27% 113
2015
Q3
$4.35M Buy
70,400
+42,400
+151% +$3.01M 0.23% 122
2015
Q2
$1.96M Buy
+28,000
New +$2.07M 0.1% 154

Other funds holding TCO

Meag Munich Ergo's TCO Position: Q4 2020 in Review

Meag Munich Ergo sold out of Taubman Centers Inc. (TCO) in Q4 2020, closing a stake of 54,450 shares — an estimated $1.81M sold.

Meag Munich Ergo first reported a position in TCO in Q2 2015 and held it in 22 quarters. The position peaked at $14.7M in Q4 2017. 4 funds tracked by Wall St. Rank hold TCO as of Q4 2020.

  • Meag Munich Ergo reported no remaining Taubman Centers Inc. position as of Q4 2020 after selling out during the quarter.
  • Meag Munich Ergo sold 54,450 Taubman Centers Inc. shares in Q4 2020, an estimated $1.81M.
  • Meag Munich Ergo first reported a position in Taubman Centers Inc. in Q2 2015 and held it in 22 quarters.
  • Meag Munich Ergo's Taubman Centers Inc. position peaked at $14.7M in Q4 2017.
  • 4 funds tracked by Wall St. Rank held Taubman Centers Inc. as of Q4 2020.

Based on Meag Munich Ergo's 13F filing for Q4 2020, filed 20 Jan 2021.